- Home
- Articles
- latamerica
- antigen targeted
Antigen Targeted Articles & Analysis
55 articles found
By binding to these antigens, antibodies can neutralize pathogens directly or mark them for destruction by other immune cells. ...
The pioneering initiative represents a major advancement in targeting cancer treatments to destroy malignant cells effectively while reducing damage to healthy tissues. ...
This specificity is achieved by linking a radioactive isotope to a monoclonal antibody or small molecule that targets specific cancer antigens. When administered, the RDCs selectively bind to the cancer cells, allowing for localized delivery of radiation. ...
Advantages of Single-Domain Antibodies Size and Specificity: Their small size enables them to penetrate tissues more effectively and reach targets that larger antibodies cannot. This characteristic enhances their specificity and affinity for antigens. ...
Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...
In biomedical research, antibodies are a powerful tool used in the detection and quantification of target antigens. However, a comprehensive understanding of the antibody requires knowledge of its amino acid sequence, which can be achieved through antibody sequencing.Antibody sequencing is a nucleic acid sequencing process that determines the nucleotide sequence ...
Compared with traditional cytotoxins, ADCs have the advantages of strong targeting, less toxic side effects, etc. They can accurately target tumor cells, reduce side effects, and improve the therapeutic effect.ADC drugs are mainly composed of monoclonal antibodies, linkers, and small molecule cytotoxins. ...
This antigen-antibody binding is a critical mechanism used by our immune system to target and eliminate threats effectively. ...
This synergistic approach allows for targeted delivery of the cytotoxic agent to cancer cells while sparing healthy tissues, thereby reducing side effects and enhancing therapeutic efficacy. ...
The Unique Value and Challenges of Peptide Antigens in Antibody DiscoveryChoosing the right antigen is crucial in antibody discovery. ...
You can use GeneNames to find the official name of the target protein, and then use GeneCards to identify aliases to expand the possible search range, because antibody suppliers may use different aliases to name the same protein.Determine Other Information of the Target ProteinDetermine the isotypes, functional domains, processed forms, structural domains with ...
Therefore, the application of computer simulation is expected to reduce reliance on expensive and time-consuming trial-and-error experiments, promoting efficient progress in antibody research and development.Main Challenges in Antibody Discovery1. Difficult to Target Antigens and Novel Drug TargetsDifficult-to-target antigens and ...
Kate Sasser from Tempus led a discussion on the potential of antibody-drug conjugates (ADCs), their challenges in targeting tumor antigens, and the future of cancer treatment with Dr. Daniel Johnson, Dr. ...
ByTempus
To ensure the effectiveness and safety of these antibody drugs, it is necessary to perform activity testing.Definition of Antibody ActivityThe activity of an antibody drug usually refers to its ability to bind to the target antigen and how it affects the target in a biological function, such as neutralizing viruses, killing tumor cells, or ...
One of the first applications of nanobodies in drug delivery was the development of targeted drug delivery systems. Nanobodies can be engineered to specifically target tissues or cells of interest by conjugating them to therapeutic agents. This targeting ability minimizes off-target effects and increases the efficacy of the drug. ...
These therapeutic antibodies aim to specifically target antigens on the surface of cells and bind to them, leading to acidic reactions that result in the destruction of target cells. ...
BOC Sciences offers a variety of linkers, including cleavable linkers, non-cleavable linkers, and pH-sensitive linkers, to accommodate different drug payloads and target antigens. These linkers are designed to be stable in circulation but release cytotoxicity upon internalization by target cancer cells, ensuring maximum therapeutic efficacy while ...
The antibody component specifically targets surface antigens on specific cancer cells, while the drug component is responsible for killing these bound cancer cells. ...
Immunohistochemistry is the study of the localization, characterization, and relative quantification of peptides and proteins in tissue cells using the antigen-antibody reaction, in which an antigen specifically binds to an antibody and a chemical reaction results in the visualization of dyes such as fluorescein and other chromogens, as well as enzymes, metal ...
As more and more ADCs enter clinical trials, the industry is gradually shifting from the use of traditional technologies to the use of newer, more robust methods to connect such complex biomolecules, including strategies using new target antigens, more powerful payloads, new linkers, and advanced coupling technologies.As a combination of macromolecules and small ...